{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:38:40Z","timestamp":1791941920419,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although studies have demonstrated the value of the triglyceride\u2013glucose (TyG) index for cardiovascular disease (CVD) and cardiovascular mortality, however, few studies have shown that the TyG index is associated with all-cause or CVD mortality in young patients with diabetes. This study aimed to investigate the association between the TyG index and all-cause and CVD mortality in young patients with diabetes in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our study recruited 2440 young patients with diabetes from the National Health and Nutrition Examination Survey (NHANES) 2001\u20132018. Mortality outcomes were determined by linking to National Death Index (NDI) records up to December 31, 2019. Cox regression modeling was used to investigate the association between TyG index and mortality in young patients with diabetes. The nonlinear association between TyG index and mortality was analyzed using restricted cubic splines (RCS), and a two-segment Cox proportional risk model was constructed for both sides of the inflection point.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up period of 8.2\u00a0years, 332 deaths from all causes and 82 deaths from cardiovascular disease were observed. Based on the RCS, the TyG index was found to have a U-shaped association with all-cause and CVD mortality in young patients with diabetes, with threshold values of 9.18 and 9.16, respectively. When the TyG index was below the threshold value (TyG index\u2009&lt;\u20099.18 in all-cause mortality and\u2009&lt;\u20099.16 in CVD mortality), its association with all-cause and CVD mortality was not significant. When the TyG index was above the threshold (TyG index\u2009\u2265\u20099.18 in all-cause mortality and\u2009\u2265\u20099.16 in CVD mortality), it showed a significant positive association with all-cause mortality and CVD mortality (HR 1.77, 95% CI 1.05\u20132.96 for all-cause mortality and HR 2.38, 95% CI 1.05\u20135.38 for CVD mortality).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results suggest a U-shaped association between TyG index and all-cause and CVD mortality among young patients with diabetes in the United States, with threshold values of 9.18 and 9.16 for CVD and all-cause mortality, respectively.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-024-02269-0","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T07:02:13Z","timestamp":1715842933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Association between the triglyceride\u2013glucose index and all-cause and CVD mortality in the young population with diabetes"],"prefix":"10.1186","volume":"23","author":[{"given":"Chang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"issue":"25","key":"2269_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2269_CR2","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139\u2013596.","journal-title":"Circulation"},{"issue":"25","key":"2269_CR3","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 2","key":"2269_CR4","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1055\/s-2001-18576","volume":"109","author":"HE Lebovitz","year":"2001","unstructured":"Lebovitz HE. Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes. 2001;109(Suppl 2):S135-148.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2269_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119: 154766.","journal-title":"Metabolism"},{"issue":"7","key":"2269_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1046\/j.1464-5491.2002.00745.x","volume":"19","author":"TM Wallace","year":"2002","unstructured":"Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med. 2002;19(7):527\u201334.","journal-title":"Diabet Med"},{"issue":"7","key":"2269_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"4","key":"2269_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"2269_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12944-020-01410-8","volume":"19","author":"A Kheirollahi","year":"2020","unstructured":"Kheirollahi A, Teimouri M, Karimi M, Vatannejad A, Moradi N, Borumandnia N, et al. Evaluation of lipid ratios and triglyceride\u2013glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women. Lipids Health Dis. 2020;19(1):235.","journal-title":"Lipids Health Dis"},{"key":"2269_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109042","volume":"180","author":"HM Park","year":"2021","unstructured":"Park HM, Lee HS, Lee YJ, Lee JH. The triglyceride\u2013glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance. Diabetes Res Clin Pract. 2021;180: 109042.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2269_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40001-024-01728-4","volume":"29","author":"H Rafiee","year":"2024","unstructured":"Rafiee H, Mohammadifard N, Nouri F, Alavi Tabatabaei G, Najafian J, Sadeghi M, et al. Association of triglyceride glucose index with cardiovascular events: insights from the Isfahan Cohort Study (ICS). Eur J Med Res. 2024;29(1):135.","journal-title":"Eur J Med Res"},{"issue":"1","key":"2269_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride\u2013glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2269_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12933-023-01924-2","volume":"22","author":"XL Cai","year":"2023","unstructured":"Cai XL, Xiang YF, Chen XF, Lin XQ, Lin BT, Zhou GY, et al. Prognostic value of triglyceride glucose index in population at high cardiovascular disease risk. Cardiovasc Diabetol. 2023;22(1):198.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2269_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12933-023-01847-y","volume":"22","author":"H Yu","year":"2023","unstructured":"Yu H, Tao L, Li YG, Yang L, Liu D, Wang Y, et al. Association between triglyceride\u2013glucose index trajectories and carotid atherosclerosis progression. Cardiovasc Diabetol. 2023;22(1):130.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2269_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12944-023-01773-8","volume":"22","author":"W Xu","year":"2023","unstructured":"Xu W, Zhao H, Han X, Liu J, Li H, Sun J, et al. Relationship between early-onset stroke and triglyceride\u2013glucose index among young Chinese adults. Lipids Health Dis. 2023;22(1):3.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2269_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12933-022-01507-7","volume":"21","author":"R Huang","year":"2022","unstructured":"Huang R, Wang Z, Chen J, Bao X, Xu N, Guo S, et al. Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure. Cardiovasc Diabetol. 2022;21(1):88.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2269_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol. 2018;17(1):83.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2269_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pcd.2019.08.004","volume":"14","author":"P Chamroonkiadtikun","year":"2020","unstructured":"Chamroonkiadtikun P, Ananchaisarp T, Wanichanon W. The triglyceride\u2013glucose index, a predictor of type 2 diabetes development: a retrospective cohort study. Prim Care Diabetes. 2020;14(2):161\u20137.","journal-title":"Prim Care Diabetes"},{"issue":"10","key":"2269_CR19","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jama.2015.10029","volume":"314","author":"A Menke","year":"2015","unstructured":"Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988\u20132012. JAMA. 2015;314(10):1021\u20139.","journal-title":"JAMA"},{"key":"2269_CR20","first-page":"1","volume":"289","author":"CD Fryar","year":"2017","unstructured":"Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D. Hypertension prevalence and control among adults: United States, 2015\u20132016. NCHS Data Brief. 2017;289:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"1","key":"2269_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-023-01819-2","volume":"22","author":"F Liu","year":"2023","unstructured":"Liu F, Ling Q, Xie S, Xu Y, Liu M, Hu Q, et al. Association between triglyceride glucose index and arterial stiffness and coronary artery calcification: a systematic review and exposure-effect meta-analysis. Cardiovasc Diabetol. 2023;22(1):111.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"2269_CR22","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.hlc.2017.05.142","volume":"27","author":"I Lambrinoudaki","year":"2018","unstructured":"Lambrinoudaki I, Kazani MV, Armeni E, Georgiopoulos G, Tampakis K, Rizos D, et al. The TyG index as a marker of subclinical atherosclerosis and arterial stiffness in lean and overweight postmenopausal women. Heart Lung Circ. 2018;27(6):716\u201324.","journal-title":"Heart Lung Circ"},{"issue":"11","key":"2269_CR23","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.21037\/jtd.2018.10.79","volume":"10","author":"JL Jin","year":"2018","unstructured":"Jin JL, Cao YX, Wu LG, You XD, Guo YL, Wu NQ, et al. Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease. J Thorac Dis. 2018;10(11):6137\u201346.","journal-title":"J Thorac Dis"},{"issue":"1","key":"2269_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-022-01576-8","volume":"21","author":"Z Wu","year":"2022","unstructured":"Wu Z, Liu L, Wang W, Cui H, Zhang Y, Xu J, et al. Triglyceride\u2013glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study. Cardiovasc Diabetol. 2022;21(1):142.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2269_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12933-023-01753-3","volume":"22","author":"Q Liu","year":"2023","unstructured":"Liu Q, Si F, Liu Z, Wu Y, Yu J. Association between triglyceride\u2013glucose index and risk of cardiovascular disease among postmenopausal women. Cardiovasc Diabetol. 2023;22(1):21.","journal-title":"Cardiovasc Diabetol"},{"key":"2269_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.628109","volume":"7","author":"XC Liu","year":"2020","unstructured":"Liu XC, He GD, Lo K, Huang YQ, Feng YQ. The triglyceride\u2013glucose index, an insulin resistance marker, was non-linear associated with all-cause and cardiovascular mortality in the general population. Front Cardiovasc Med. 2020;7: 628109.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2269_CR27","doi-asserted-by":"publisher","first-page":"16478","DOI":"10.1038\/s41598-023-43512-0","volume":"13","author":"M Zhao","year":"2023","unstructured":"Zhao M, Xiao M, Tan Q, Lu F. Triglyceride glucose index as a predictor of mortality in middle-aged and elderly patients with type 2 diabetes in the US. Sci Rep. 2023;13(1):16478.","journal-title":"Sci Rep"},{"issue":"1","key":"2269_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride\u2013glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"46","key":"2269_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017995","volume":"98","author":"J Shang","year":"2019","unstructured":"Shang J, Yu D, Cai Y, Wang Z, Zhao B, Zhao Z, et al. The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: a nested case control study. Medicine (Baltimore). 2019;98(46): e17995.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"2269_CR30","first-page":"521","volume":"40","author":"G Kozdag","year":"2013","unstructured":"Kozdag G, Ertas G, Emre E, Akay Y, Celikyurt U, Sahin T, et al. Low serum triglyceride levels as predictors of cardiac death in heart failure patients. Tex Heart Inst J. 2013;40(5):521\u20138.","journal-title":"Tex Heart Inst J"},{"issue":"1","key":"2269_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2010.05.006","volume":"212","author":"WS Ryu","year":"2010","unstructured":"Ryu WS, Lee SH, Kim CK, Kim BJ, Yoon BW. Effects of low serum triglyceride on stroke mortality: a prospective follow-up study. Atherosclerosis. 2010;212(1):299\u2013304.","journal-title":"Atherosclerosis"},{"issue":"1","key":"2269_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12877-022-03155-8","volume":"22","author":"M Sun","year":"2022","unstructured":"Sun M, Guo H, Wang Y, Ma D. Association of triglyceride glucose index with all-cause and cause-specific mortality among middle age and elderly US population. BMC Geriatr. 2022;22(1):461.","journal-title":"BMC Geriatr"},{"issue":"1","key":"2269_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12877-023-03788-3","volume":"23","author":"J Shen","year":"2023","unstructured":"Shen J, Feng B, Fan L, Jiao Y, Li Y, Liu H, et al. Triglyceride glucose index predicts all-cause mortality in oldest-old patients with acute coronary syndrome and diabetes mellitus. BMC Geriatr. 2023;23(1):78.","journal-title":"BMC Geriatr"},{"issue":"1","key":"2269_CR34","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S2666-7568(22)00247-1","volume":"4","author":"P Lopez-Jaramillo","year":"2023","unstructured":"Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, Abat MEM, Alhabib KF, Avezum \u00c1, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2023;4(1):e23\u201333.","journal-title":"Lancet Healthy Longev"},{"issue":"2","key":"2269_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/1753944711403189","volume":"5","author":"P Lopez-Jaramillo","year":"2011","unstructured":"Lopez-Jaramillo P, Lahera V, Lopez-Lopez J. Epidemic of cardiometabolic diseases: a Latin American point of view. Ther Adv Cardiovasc Dis. 2011;5(2):119\u201331.","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"8","key":"2269_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11886-016-0755-4","volume":"18","author":"AE Brown","year":"2016","unstructured":"Brown AE, Walker M. Genetics of insulin resistance and the metabolic syndrome. Curr Cardiol Rep. 2016;18(8):75.","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"2269_CR37","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"2269_CR38","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Investig. 2006;116(7):1793\u2013801.","journal-title":"J Clin Investig"},{"issue":"12","key":"2269_CR39","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1172\/JCI200319451","volume":"112","author":"H Xu","year":"2003","unstructured":"Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Investig. 2003;112(12):1821\u201330.","journal-title":"J Clin Investig"},{"issue":"1","key":"2269_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/01.ATV.0000048856.22331.50","volume":"23","author":"M Kumada","year":"2003","unstructured":"Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003;23(1):85\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2269_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2141.2012.09074.x","volume":"157","author":"T Iwaki","year":"2012","unstructured":"Iwaki T, Urano T, Umemura K. PAI-1, progress in understanding the clinical problem and its aetiology. Br J Haematol. 2012;157(3):291\u20138.","journal-title":"Br J Haematol"},{"issue":"6","key":"2269_CR42","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/db09-1008","volume":"59","author":"AJ Gerrits","year":"2010","unstructured":"Gerrits AJ, Koekman CA, van Haeften TW, Akkerman JW. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes. 2010;59(6):1487\u201395.","journal-title":"Diabetes"},{"issue":"10","key":"2269_CR43","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41580-018-0044-8","volume":"19","author":"Q Yang","year":"2018","unstructured":"Yang Q, Vijayakumar A, Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol. 2018;19(10):654\u201372.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"2269_CR44","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12(3):144\u201353.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2269_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ddstr.2008.02.001","volume":"5","author":"JA Leopold","year":"2008","unstructured":"Leopold JA, Loscalzo J. Oxidative mechanisms and atherothrombotic cardiovascular disease. Drug Discov Today Ther Strateg. 2008;5(1):5\u201313.","journal-title":"Drug Discov Today Ther Strateg"},{"issue":"17","key":"2269_CR46","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1136\/heartjnl-2019-316243","volume":"106","author":"PJ Grant","year":"2020","unstructured":"Grant PJ, Cosentino F, Marx N. Diabetes and coronary artery disease: not just a risk factor. Heart. 2020;106(17):1357\u201364.","journal-title":"Heart"},{"key":"2269_CR47","doi-asserted-by":"publisher","first-page":"1039241","DOI":"10.3389\/fimmu.2022.1039241","volume":"13","author":"D Zheng","year":"2022","unstructured":"Zheng D, Liu J, Piao H, Zhu Z, Wei R, Liu K. ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis. Front Immunol. 2022;13:1039241.","journal-title":"Front Immunol"},{"key":"2269_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114775","volume":"163","author":"L Shu","year":"2023","unstructured":"Shu L, Yuan Z, Li F, Cai Z. Oxidative stress and valvular endothelial cells in aortic valve calcification. Biomed Pharmacother. 2023;163: 114775.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2269_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-015-0615-4","volume":"18","author":"MN Molina","year":"2016","unstructured":"Molina MN, Ferder L, Manucha W. Emerging role of nitric oxide and heat shock proteins in insulin resistance. Curr Hypertens Rep. 2016;18(1):1.","journal-title":"Curr Hypertens Rep"},{"issue":"Suppl 1","key":"2269_CR50","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1016\/j.diabres.2007.01.071","volume":"77","author":"T Nishikawa","year":"2007","unstructured":"Nishikawa T, Kukidome D, Sonoda K, Fujisawa K, Matsuhisa T, Motoshima H, et al. Impact of mitochondrial ROS production in the pathogenesis of insulin resistance. Diabetes Res Clin Pract. 2007;77(Suppl 1):S161-164.","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02269-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02269-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02269-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T08:04:19Z","timestamp":1715846659000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02269-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2269"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02269-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the NCHS Research Ethics Review Board (ERB). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be recognized as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}